• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[与普通外科健康受试者及内科老年受试者皮下注射的未分级肝素相比,3种低分子量肝素(PK 10169、卡比2165和CY 216)诱导的生物学改变]

[Biological modifications induced by 3 low molecular weight heparins, PK 10169, Kabi 2165 and CY 216, compared to unfractionated heparin injected subcutaneously in healthy subjects in general surgery and in aged subjects in internal medicine].

作者信息

Bara L, Combe-Tamzali S, Conard J, Horellou M H, Samama M

机构信息

Laboratoire Central d'Hématologie, Hôtel-Dieu, Paris.

出版信息

J Mal Vasc. 1987;12 Suppl B:78-84.

PMID:2834498
Abstract

Activities of anti-Xaam, anti-IIaam, Heptest and calcium thrombin time (Ca TT) were compared in: 12 male healthy volunteers after increasing doses of 20, 40, 60 and 80 mg/day of Enoxaparine; 76 patients after gynecological surgery treated with 20 mg (12 cases), 40 mg (15 cases) or 60 mg (10 cases) per day of Enoxaparine versus calcium heparin as 5,000 IU x 3/day (39 cases); 68 patients after general surgery treated with 2,500 units Fragmine/day (34 cases) versus calcium heparin 5,000 IU x 2/day (34 cases); 27 patients in a medical ward treated with either 7,500 Choay Institute units/day of Fraxiparine (14 cases) or Cutheparine (magnesium heparinate) (13 cases). In this latter case results of Heptest only are reported. In healthy volunteers and patients after gynecological operations, the Ca TT and anti-IIaam activity were significantly modified after doses greater than or equal to 40 mg. Values for anti-Xaam and anti-IIaam were dose-related but higher in healthy volunteers. The anti-Xa/anti-IIa ratio was 3-4. Correlation between Heptest, a simple test, and anti-Xa activity--both very good markers of low molecular weight heparins (LMWH)--was very good (r = 0.93, p less than 0.02 in healthy volunteers; r = 0.87, p less than 0.01 in operated patients). Peak activity was at about 3 to 4 hours after injection, the half-life of anti-Xa and anti-IIa activities being 4 and 2 hours respectively. After heparin injection, the anti-Xa/anti-IIa ratio was 1 but activities were weak (5,000 IU x 2 = 0.02 +/- 0.02), a little higher with 5,000 IU x 3 (0.05 +/- 0.04).(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

比较了抗Xa活性、抗IIa活性、希普试验(Heptest)和钙凝血酶时间(Ca TT)在以下几组中的情况:12名男性健康志愿者,接受递增剂量(每日20、40、60和80毫克)的依诺肝素;76名妇科手术后患者,分别接受每日20毫克(12例)、40毫克(15例)或60毫克(10例)的依诺肝素治疗,与每日5000国际单位×3次的钙肝素治疗(39例)进行对比;68名普通外科手术后患者,分别接受每日2500单位弗拉明(Fragmine)治疗(34例)与每日5000国际单位×2次的钙肝素治疗(34例);27名内科病房患者,分别接受每日7500乔艾研究所单位的速避凝(Fraxiparine)治疗(14例)或可塞灵(Cutheparine,肝素镁)治疗(13例)。在后一种情况下,仅报告了希普试验的结果。在健康志愿者和妇科手术后患者中,剂量大于或等于40毫克后,Ca TT和抗IIa活性有显著改变。抗Xa活性和抗IIa活性的值与剂量相关,但在健康志愿者中更高。抗Xa/抗IIa比值为3至4。希普试验(一种简单的检测方法)与抗Xa活性之间的相关性很好,这两者都是低分子肝素(LMWH)的良好标志物(在健康志愿者中r = 0.93,p < 0.02;在手术患者中r = 0.87,p < 0.01)。峰值活性在注射后约3至4小时出现,抗Xa和抗IIa活性的半衰期分别为4小时和2小时。注射肝素后,抗Xa/抗IIa比值为1,但活性较弱(5000国际单位×2 = 0.02 ± 0.02),5000国际单位×3时略高(0.05 ± 0.04)。(摘要截取自250字)

相似文献

1
[Biological modifications induced by 3 low molecular weight heparins, PK 10169, Kabi 2165 and CY 216, compared to unfractionated heparin injected subcutaneously in healthy subjects in general surgery and in aged subjects in internal medicine].[与普通外科健康受试者及内科老年受试者皮下注射的未分级肝素相比,3种低分子量肝素(PK 10169、卡比2165和CY 216)诱导的生物学改变]
J Mal Vasc. 1987;12 Suppl B:78-84.
2
Clinical evaluation of a new one-stage clotting assay for heparin and low molecular weight heparins.一种新型肝素和低分子肝素一步凝血检测法的临床评估
J Mal Vasc. 1987;12 Suppl B:68-70.
3
Pharmacokinetics of low molecular weight heparins.低分子量肝素的药代动力学
Acta Chir Scand Suppl. 1988;543:65-72.
4
Comparative effects of enoxaparin and unfractionated heparin in healthy volunteers on prothrombin consumption in whole blood during coagulation, and release of tissue factor pathway inhibitor.依诺肝素与普通肝素对健康志愿者凝血过程中全血凝血酶原消耗及组织因子途径抑制物释放的比较作用。
Thromb Res. 1993 Mar 1;69(5):443-52. doi: 10.1016/0049-3848(93)90233-e.
5
Pharmacodynamics of intravenous and subcutaneous tinzaparin and heparin in healthy volunteers.静脉注射和皮下注射替扎肝素及肝素在健康志愿者中的药效学
Am J Health Syst Pharm. 2001 Sep 1;58(17):1614-21. doi: 10.1093/ajhp/58.17.1614.
6
Correlation between anti-Xa and occurrence of thrombosis and haemorrhage in post-surgical patients treated with either Logiparin (LMWH) or unfractionated heparin. Post-surgery Logiparin Study Group.接受洛吉派林(低分子肝素)或普通肝素治疗的外科手术后患者中,抗Xa水平与血栓形成及出血发生之间的相关性。术后洛吉派林研究组。
Thromb Res. 1992 Mar 1;65(4-5):641-50. doi: 10.1016/0049-3848(92)90213-t.
7
A comparative study of three low-molecular weight heparins (LMWH) and unfractionated heparin (UH) in healthy volunteers.健康志愿者中三种低分子量肝素(LMWH)与普通肝素(UH)的对比研究。
Thromb Haemost. 1995 Mar;73(3):398-401.
8
Unfractionated heparin and CY 216: pharmacokinetics and bioavailabilities of the antifactor Xa and IIa effects after intravenous and subcutaneous injection in the rabbit.普通肝素与CY 216:兔静脉注射和皮下注射后抗Xa因子和抗IIa因子作用的药代动力学及生物利用度
Thromb Haemost. 1989 Jun 30;61(3):348-53.
9
Plasma thrombin neutralization assay: pharmacokinetic applications.血浆凝血酶中和试验:药代动力学应用。
Semin Thromb Hemost. 1994;20(3):266-73. doi: 10.1055/s-2007-1001912.
10
In vitro effect on Heptest of low molecular weight heparin fractions and preparations with various anti-IIa and anti-Xa activities.
Thromb Res. 1990 Feb 15;57(4):585-92. doi: 10.1016/0049-3848(90)90075-n.

引用本文的文献

1
Dalteparin: an update of its pharmacological properties and clinical efficacy in the prophylaxis and treatment of thromboembolic disease.达肝素:其在预防和治疗血栓栓塞性疾病方面的药理特性及临床疗效的最新进展
Drugs. 2000 Jul;60(1):203-37. doi: 10.2165/00003495-200060010-00010.
2
Dalteparin sodium. A review of its pharmacology and clinical use in the prevention and treatment of thromboembolic disorders.达肝素钠。其药理学及在预防和治疗血栓栓塞性疾病中的临床应用综述。
Drugs. 1996 Aug;52(2):276-305. doi: 10.2165/00003495-199652020-00011.